Coherus Oncology, Inc.
CHRS
$1.13
-$0.04-3.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -118.02M | -130.94M | 28.51M | -450.00K | -29.34M |
| Total Depreciation and Amortization | 3.63M | 4.82M | 5.28M | 5.31M | 4.66M |
| Total Amortization of Deferred Charges | 4.16M | 4.16M | 4.16M | 2.41M | 2.41M |
| Total Other Non-Cash Items | 47.13M | 44.33M | -114.28M | -76.97M | -73.63M |
| Change in Net Operating Assets | 3.87M | 78.13M | 55.89M | 7.73M | 41.64M |
| Cash from Operations | -59.23M | 500.00K | -20.44M | -61.99M | -54.27M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 7.00M |
| Divestitures | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Other Investing Activities | -17.58M | 10.07M | 230.32M | 266.07M | 309.17M |
| Cash from Investing | -17.58M | 10.07M | 230.32M | 266.07M | 316.17M |
| Total Debt Issued | -141.00K | 36.98M | 36.98M | 36.98M | 37.12M |
| Total Debt Repaid | 0.00 | -260.39M | -260.39M | -260.39M | -260.39M |
| Issuance of Common Stock | 241.00K | 874.00K | 2.38M | 3.03M | 14.52M |
| Repurchase of Common Stock | -284.00K | -2.00M | -2.48M | -2.79M | -2.96M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.00K | 36.40M | 36.53M | 36.33M | 36.14M |
| Cash from Financing | -200.00K | -188.13M | -186.97M | -186.84M | -175.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.02M | -177.55M | 22.91M | 17.24M | 86.33M |